To shed light on this issue, we studied the mRNA expression of CD200 and CX3CR1 (also known as fractalkine receptors), which have been associated with inhibitory actions on brain microglia[76], and MCP-1, a potent chemokine which has been implicated in different neurological disorders[77]. This evidence concerns the gene CCL2 and nervous system disorder.